{
"id": "https://doi.org/10.5281/zenodo.4063888",
"doi": "10.5281/ZENODO.4063888",
"url": "https://zenodo.org/record/4063888",
"types": {
"ris": "DATA",
"bibtex": "misc",
"citeproc": "dataset",
"schemaOrg": "Dataset",
"resourceTypeGeneral": "Dataset"
},
"creators": [
{
"name": "Ranucci M",
"affiliation": [
{
"name": "Department of Cardiothoracic, Vascular Anaesthesia and Intensive Care, IRCCS Policlinico San Donato, Milan, Italy."
}
],
"nameIdentifiers": []
},
{
"name": "Aloisio T,",
"familyName": "Aloisio T",
"affiliation": [
{
"name": "Department of Cardiothoracic, Vascular Anaesthesia and Intensive Care, IRCCS Policlinico San Donato, Milan, Italy."
}
]
},
{
"name": "U, Di Dedda",
"nameType": "Personal",
"givenName": "Di Dedda",
"familyName": "U",
"affiliation": [
{
"name": "Department of Cardiothoracic, Vascular Anaesthesia and Intensive Care, IRCCS Policlinico San Donato, Milan, Italy."
}
],
"nameIdentifiers": []
},
{
"name": "Menicanti L",
"affiliation": [
{
"name": "Department of Cardiac Surgery, IRCCS Policlinico San Donato, Milan Italy."
}
],
"nameIdentifiers": []
},
{
"name": "C, De Vincentiis",
"nameType": "Personal",
"givenName": "De Vincentiis",
"familyName": "C",
"affiliation": [
{
"name": "Department of Cardiac Surgery, IRCCS Policlinico San Donato, Milan Italy."
}
],
"nameIdentifiers": []
},
{
"name": "Baryshnikova E;",
"affiliation": [
{
"name": "Department of Cardiothoracic, Vascular Anaesthesia and Intensive Care, IRCCS Policlinico San Donato, Milan, Italy."
}
],
"nameIdentifiers": []
}
],
"titles": [
{
"title": "Data set from Ranucci M, Aloisio T, Di Dedda U, Menicanti L, de Vincentiis C, Baryshnikova E; Surgical and Clinical Outcome REsearch (SCORE) group. Gender-based differences in platelet function and platelet reactivity to P2Y12 inhibitors. PLoS One. 2019 Nov 27;14(11):e0225771. doi: 10.1371/journal.pone.0225771. PMID: 31774869; PMCID: PMC6881030."
}
],
"publisher": {
"name": "Zenodo"
},
"container": {
"type": "DataRepository",
"identifier": "https://zenodo.org/communities/irccspoliclinicosandonato",
"identifierType": "URL"
},
"subjects": [],
"contributors": [],
"dates": [
{
"date": "2020-10-02",
"dateType": "Issued"
}
],
"publicationYear": 2020,
"language": "en",
"identifiers": [],
"sizes": [],
"formats": [],
"rightsList": [
{
"rights": "Restricted Access",
"rightsUri": "info:eu-repo/semantics/restrictedAccess"
}
],
"descriptions": [
{
"description": "Data set from Ranucci M, Aloisio T, Di Dedda U, Menicanti L, de Vincentiis C, Baryshnikova E; Surgical and Clinical Outcome REsearch (SCORE) group. Gender-based differences in platelet function and platelet reactivity to P2Y12 inhibitors. PLoS One. 2019 Nov 27;14(11):e0225771. doi: 10.1371/journal.pone.0225771. PMID: 31774869; PMCID: PMC6881030. This is the article: Background: Gender influences platelet biology. Women have a larger platelet count, but gender-based differences in platelet function remain debated. We performed a study addressing gender-based differences in platelet function using point-of-care platelet function tests (PFT). Methods: The patient population consisted of 760 cardiac surgery patients where preoperative PFT (multiple-electrode aggregometry [MEA]) were available. Platelet count and function at the ADPtest and TRAPtest were compared in the overall population and separately in patients with or without residual effects of P2Y12 inhibitors. Results: Women had a significantly (P = 0.001) higher platelet count but a non-significantly higher platelet reactivity to ADP. In clopidogrel-treated patients, the platelets ADP reactivity was significantly (P = 0.031) higher in women, and platelet count was the main determinant of platelet hyper-reactivity. Within patients under full clopidogrel effects, women with a platelet count ≥ 200,000 cells/μL had a significantly (P = 0.023) higher rate of high-on-treatment platelet reactivity (HTPR, 45.5%) with respect to males with a platelet count < 200,000 cells/μL (11.9%), with a relative risk of 6.2 (95% confidence interval 1.4-29). Conclusions: Our findings confirm that women have a larger platelet count than men, and that this is associated to a trend towards a higher platelet reactivity. HTPR is largely represented in women with a high platelet count. This generates the hypothesis that women requiring P2Y12 inhibitors could potentially benefit from larger doses of drug or should be treated with anti-platelet agents with a low rate of HTPR.",
"descriptionType": "Abstract"
}
],
"geoLocations": [],
"fundingReferences": [],
"relatedIdentifiers": [
{
"relationType": "IsVersionOf",
"relatedIdentifier": "10.5281/zenodo.4063887",
"relatedIdentifierType": "DOI"
},
{
"relationType": "IsPartOf",
"relatedIdentifier": "https://zenodo.org/communities/irccspoliclinicosandonato",
"relatedIdentifierType": "URL"
}
],
"schemaVersion": "http://datacite.org/schema/kernel-4",
"providerId": "cern",
"clientId": "cern.zenodo",
"agency": "datacite",
"state": "findable"
}